MBP Inc. supplies mutation detection kits for verifying CRISPR/Cas9 editing outcomes — including T7 endonuclease I (T7E1) assays, Surveyor nuclease kits, and PCR-based indel detection systems. These tools confirm insertions and deletions in edited mammalian genomic DNA using standard gel electrophoresis, making post-edit validation accessible to any research lab in the USA and Canada.
MBP supplies ABM mutation detection kits to support sensitive and reliable mutation analysis workflows. Contact customerservice@mbpinc.net today to request a quote and find the right solution for your research.
Mutation detection kits confirm that CRISPR/Cas9 (or TALEN/ZFN) editing has produced the intended insertions or deletions (indels) before researchers proceed to downstream experiments. Enzymatic mismatch cleavage (EMC) assays, primarily T7 endonuclease I (T7E1) and Surveyor nuclease, are the most widely adopted method due to their simplicity and compatibility with standard molecular biology infrastructure. Reliable mutation detection is essential for confirming genetic variants and genome-editing outcomes. Select the kit that aligns with your analytical requirements.
Genomic Cleavage Detection Assays: Specialized kits designed to quantify indel frequency via T7E1 or Surveyor nuclease-mediated mismatch recognition.
Screen It™ CRISPR Cas9 Systems: High-throughput compatible tools for streamlined validation of locus-specific modifications with minimal sequence bias.
Mutation Type
T7E1 offers higher sensitivity for insertions and deletions (indels), making it the preferred first-line tool for confirming CRISPR knockout experiments. Surveyor nuclease performs better for single-nucleotide substitutions.
Required Resolution
EMC assays (T7E1, Surveyor) serve as rapid, cost-effective screening tools, typically detecting indel frequencies down to 2–5% in a mixed population. For more precise quantification at lower frequencies, NGS-based methods such as TIDE or targeted amplicon sequencing are recommended.
Equipment Available
T7E1 and Surveyor assays require only a thermal cycler, standard PCR reagents, agarose gel electrophoresis equipment, and a UV transilluminator — all standard in most molecular biology labs, with no specialised equipment needed.
Editing Technology Compatibility
Mutation detection kits in MBP's catalogue are compatible with CRISPR/Cas9 (all Cas9 variants), CRISPR/Cas12 systems, TALENs, and zinc finger nucleases (ZFNs), as well as a range of model organisms beyond mammalian cell lines.
Throughput Needs
PCR-based mutation detection assays run in parallel across many samples in a single thermal cycler run, making them well-suited to high-throughput clone screening after bulk editing confirmation.
The T7E1 workflow involves four steps: PCR amplification of the target region, denaturation and re-annealing to form heteroduplexes, enzymatic digestion with T7E1 (which cleaves mismatched DNA), and gel analysis, where the ratio of cut to uncut bands estimates editing efficiency. Research published in G3: Genes|Genomes|Genetics shows T7E1 outperforms Surveyor for detecting deletions, while Surveyor has advantages for point mutations. A positive T7E1 result confirms indel presence but not the exact sequence; Sanger sequencing or targeted NGS typically follows to characterise the edit. Running a known-positive control alongside experimental samples -- for example, a previously validated guide RNA targeting the same locus -- helps confirm the T7E1 digestion conditions are working correctly before interpreting negative results as a failed edit. Product availability reflects MBP's catalogue as of mid-2026.
Contact the expert team at MBP Inc. today to request a quote for the right mutation detection kit for your lab.